Anti-Asthmatics And Copd Drugs Market - By Type Of Therapy (Preventive, Curative), By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By End-Users (Asthma Patients, Copd Patients), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000 | Pages : 309 | Published : April 2020 | SKU CODE : o&s130 | Format :

Request Sample

The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The class of drugs includes Bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.  The global anti-asthmatics and copd drugs market is expected to grow from $52 billion in 2019 to $77.3 billion in 2020 at a compound annual growth rate (CAGR) of 48.8%. The respiratory drugs market witnessed significant growth mainly due to the COVID-19 outbreak. The fact that Covid-19 is essentially a respiratory ailment has boosted the market growth. The market is then expected to grow at a CAGR of 5.7% from 2021 and reach $83.8 billion in 2023.  North America was the largest region in the anti-asthmatics and COPD drugs market in 2017.  Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market. Even though there is a decreasing trend of smoking prevalence globally, developing countries such as China, India, Indonesia, and Nigeria among others have increasing smoking prevalence. For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria from 2015 to 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high income countries including USA and Europe. According to WHO, in developed countries more than 35% of total energy requirement is derived from fats when compared to <20% in low income countries, and <25% in lower middle income countries.   Increasing patent expiration of innovator drugs is restraining the anti-asthamatics and COPD drug market. Due to patent expiration, generic drugs are entering the market which are inexpensive when compared to innovator drugs. For example, patent for Advair Diskus inhaler by GSK has expired in 2016, and many players including Novartis, Hikama, and Mylan are trying to get FDA approval for a generic version of the innovator drug.  The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient reported outcomes (PROs) compared to monotherapies. For example, combination of short acting beta agonists (SABA) and short acting muscarinic antagnoists (SAMA) are superior compared to either medication alone in improving lung function. The use of combination long acting beta agonists (LABA), and long acting muscarnic antagonists (LAMA) have improved lung function than long acting monotherapy bronchodilators.  Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren`t necessarily """"official"""" direct alternatives to CFC Metered Dose Inhalers, but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking.

NULL

The major players covered in the global anti-asthmatics and copd drugs market are Novartis AG, Merck & Co, GlaxoSmithKline , Boehringer Ingelheim Gmbh, AstraZeneca, Roche , Teva Pharmaceutical , Vectura , Pfizer , Abbott , Mylan , Allergan , Cipla , Akorn.

The countries covered in the global anti-asthmatics and copd drugs market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia. The regions covered in the global anti-asthmatics and copd drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global anti-asthmatics and copd drugs market is segmented -
1) By Drug Class: Bronchodilators , Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs .
2) By End User: Asthma Patients, COPD Patients .
3) By Distribution Channel: Hospital Pharmacies , Private Clinics , Drug Stores , Retail Pharmacies , E-Commerce .

  1. 1. Anti-Asthmatics And COPD Drugs Market Executive Summary
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Drug Class
    • 6.1.3. Segmentation By End User
    • 6.1.4. Segmentation By Distribution Channel
    • 6.1.5. Segmentation By Therapy
    • 6.1.6. Segmentation By Route Of Administration
    • 6.1.7. Segmentation By Age Group
    • 6.1.8. Segmentation By Prescription
    • 6.1.9. Segmentation By Drug Type
  7. 7. Anti-Asthmatics And COPD Drugs Market Characteristics
    • 7.1. Market Segmentation By Class
      • 7.1.1. Bronchodilators
      • 7.1.2. Anti-Inflammatory Drugs
      • 7.1.3. Monoclonal Antibodies
      • 7.1.4. Combination Drugs
    • 7.2. Market Segmentation By End User
      • 7.2.1. Asthma Patients
      • 7.2.2. COPD Patients
    • 7.3. Market Segmentation By Distribution Channel
      • 7.3.1. Hospital Pharmacies
      • 7.3.2. General Pharmacies
      • 7.3.3. Online Retailers
    • 7.4. Market Segmentation By Therapy
      • 7.4.1. Preventive
      • 7.4.2. Curative
    • 7.5. Market Segmentation By Route Of Administration
      • 7.5.1. Oral
      • 7.5.2. Inhaled
      • 7.5.3. Intravenous
      • 7.5.4. Subcutaneous
    • 7.6. Market Segmentation By Age Group
      • 7.6.1. Below 5
      • 7.6.2. 5-14
      • 7.6.3. 15-60
      • 7.6.4. Above 60
    • 7.7. Market Segmentation By Prescription
      • 7.7.1. Prescription
      • 7.7.2. Over The Counter (OTC)
    • 7.8. Market Segmentation By Drug Type
      • 7.8.1. Branded
      • 7.8.2. Generic
  8. 8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis
    • 8.1.1. Raw Material And Equipment Procurement
    • 8.1.2. Manufacturing, Processing and Packaging
    • 8.1.3. Distribution
    • 8.1.4. Physicians
    • 8.1.5. End users
  9. 9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  10. 10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales
    • 10.1.1. Ellipta
    • 10.1.2. Spiriva
    • 10.1.3. Symbicort
    • 10.1.4. Advair
    • 10.1.5. Pulmicort
    • 10.1.6. Ventolin
    • 10.1.7. Xolair
    • 10.1.8. Nucala
    • 10.1.9. Flovent
    • 10.1.10. Fasenra
  11. 11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs
    • 11.1.1. Background
    • 11.1.2. Innovators
  12. 12. Anti-Asthmatics And COPD Drugs Market, Customer Information
    • 12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese
    • 12.2. Britons Experience Inadequate Treatment Of COPD
    • 12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers
    • 12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits
    • 12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues
  13. 13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market
    • 13.1. Consumer Perception
    • 13.2. High Mortality Among Asthma Patients
    • 13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment
  14. 14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
    • 14.1.1. India
    • 14.1.2. China
    • 14.1.3. Japan
    • 14.1.4. Australia
    • 14.1.5. South Korea
    • 14.1.6. Indonesia
    • 14.1.7. USA
    • 14.1.8. Canada
    • 14.1.9. Mexico
    • 14.1.10. UK
    • 14.1.11. Germany
    • 14.1.12. France
    • 14.1.13. Russia
    • 14.1.14. Brazil
  15. 15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
    • 15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market
    • 15.2. Increasing Demand For Personalized Medicines
    • 15.3. Demand For Aerosol Respiratory Drugs
    • 15.4. Use Of Biomarker For Precision Medicine
    • 15.5. Rise Of Generic Respiratory Drugs
    • 15.6. Combination Drug Therapy To Treat COPD
    • 15.7.New Biologic Therapy Medicines To Treat Severe Asthma
  16. 16. Asthma And COPD Prevalence Overview
    • 16.1. Asthma
    • 16.2. COPD
  17. 17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth
    • 17.1. Market Size
    • 17.2. Historic Market Growth, 2015 – 2019, Value ($ Million)
      • 17.2.1. Historic Drivers Of The Market 2015-2019
      • 17.2.2. Historic Restraints Of The Market 2015-2019
    • 17.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
      • 17.3.1. Forecast Drivers Of The Market 2019-2023
      • 17.3.2. Forecast Restraints Of The Market 2019-2023
  18. 18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis
    • 18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  19. 19. Global Anti-Asthmatics And COPD Drugs Market Segmentation
    • 19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.1.1. Combination Drugs
      • 19.1.2. Bronchodilators
      • 19.1.3. Monoclonal Antibodies
      • 19.1.4. Anti-Inflammatory Drugs
    • 19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.2.1. Asthma Patients
      • 19.2.2. COPD Patients
    • 19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.3.1. General Pharmacies
      • 19.3.2. Hospital Pharmacies
      • 19.3.3. Online Retailers
    • 19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value ($ Million)
      • 19.4.1. Preventive
      • 19.4.2. Curative
    • 19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value ($ Million)
      • 19.5.1. Inhaled
      • 19.5.2. Intravenous and Subcutaneous
      • 19.5.3. Oral
    • 19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019, Value ($ Million)
      • 19.6.1. 15-69 Years
      • 19.6.2. 70+ Years
      • 19.6.3. Below 5 Years
    • 19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value ($ Million)
      • 19.7.1. Prescription
      • 19.7.2. OTC
    • 19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value ($ Million)
      • 19.8.1. Branded
      • 19.8.2. Generics
  20. 20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
    • 20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
      • 20.1.1. Region Information
      • 20.1.2. Market Information
      • 20.1.3. Background Information
      • 20.1.4. Government Initiatives
      • 20.1.5. New Drug Trials And Approvals
      • 20.1.6. Major Associations
      • 20.1.7. Taxes Levied
      • 20.1.8. Investments
      • 20.1.9. Major Companies
    • 20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 20.7. China Anti-Asthmatics And COPD Drugs Market
    • 20.8. China Anti-Asthmatics And COPD Drugs Market Overview
      • 20.8.1. Country Information
      • 20.8.2. Market Information
      • 20.8.3. Background Information
      • 20.8.4. Government Initiatives
      • 20.8.5. New Drug Trials And Approvals
      • 20.8.6. Major Associations
      • 20.8.7. Taxes Levied
      • 20.8.8. Investments
      • 20.8.9. Major Companies
    • 20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.13. India Anti-Asthmatics And COPD Drugs Market
    • 20.14. India Anti-Asthmatics And COPD Drugs Market Overview
      • 20.14.1. Country Information
      • 20.14.2. Market Information
      • 20.14.3. Background Information
      • 20.14.4. Government Initiatives
      • 20.14.5. Major Associations
      • 20.14.6. Taxes Levied
      • 20.14.7. Investments
      • 20.14.8. Major Companies
    • 20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.19. Japan Anti-Asthmatics And COPD Drugs Market
    • 20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview
      • 20.20.1. Country Information
      • 20.20.2. Market Information
      • 20.20.3. Background Information
      • 20.20.4. Government Initiatives
      • 20.20.5. New Drug Trials And Approvals
      • 20.20.6. Major Associations
      • 20.20.7. Taxes Levied
      • 20.20.8. Investments
      • 20.20.9. Major Companies
    • 20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.25. Australia Anti-Asthmatics And COPD Drugs Market
    • 20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.30. Indonesia Anti-Asthmatics And COPD Drugs Market
    • 20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.35. South Korea Anti-Asthmatics And COPD Drugs Market
    • 20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  21. 21. Western Europe Anti-Asthmatics And COPD Drugs Market
    • 21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
      • 21.1.1. Region Information
      • 21.1.2. Market Information
      • 21.1.3. Background Information
      • 21.1.4. Government Initiatives
      • 21.1.5. New Drug Trials And Approvals
      • 21.1.6. Major Associations
      • 21.1.7. Taxes Levied
      • 21.1.8. Major Companies
    • 21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 21.7. UK Anti-Asthmatics And COPD Drugs Market
    • 21.8. UK Anti-Asthmatics And COPD Drugs Market Overview
      • 21.8.1. Country Information
      • 21.8.2. Market Information
      • 21.8.3. Background Information
      • 21.8.4. Government Initiatives
      • 21.8.5. New Drug Trials And Approvals
      • 21.8.6. Major Associations
      • 21.8.7. Taxes Levied
      • 21.8.8. Major Companies
    • 21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.13. Germany Anti-Asthmatics And COPD Drugs Market
    • 21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.18. France Anti-Asthmatics And COPD Drugs Market
    • 21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  22. 22. Eastern Europe Anti-Asthmatics And COPD Drugs Market
    • 22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
      • 22.1.1. Region Information
      • 22.1.2. Market Information
      • 22.1.3. Background Information
      • 22.1.4. New Drug Trials And Approvals
      • 22.1.5. Major Associations
      • 22.1.6. Taxes Levied
      • 22.1.7. Major Companies
    • 22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.6. Russia Anti-Asthmatics And COPD Drugs Market
    • 22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  23. 23. North America Anti-Asthmatics And COPD Drugs Market
    • 23.1. North America Anti-Asthmatics And COPD Drugs Market Overview
      • 23.1.1. Region Information
      • 23.1.2. Market Information
      • 23.1.3. Background Information
      • 23.1.4. Government Initiatives
      • 23.1.5. New Drug Trials And Approvals
      • 23.1.6. Major Associations
      • 23.1.7. Taxes Levied
      • 23.1.8. Investments
      • 23.1.9. Major Companies
    • 23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 23.7. USA Anti-Asthmatics And COPD Drugs Market
    • 23.8. USA Anti-Asthmatics And COPD Drugs Market Overview
      • 23.8.1. Country Information
      • 23.8.2. Market Information
      • 23.8.3. Background Information
      • 23.8.4. Government Initiatives
      • 23.8.5. Major Associations
      • 23.8.6. Taxes Levied
      • 23.8.7. Investments
      • 23.8.8. Major Companies
    • 23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  24. 24. South America Anti-Asthmatics And COPD Drugs Market
    • 24.1. South America Anti-Asthmatics And COPD Drugs Market Overview
      • 24.1.1. Region Information
      • 24.1.2. Market Information
      • 24.1.3. Background Information
      • 24.1.4. Major Associations
      • 24.1.5. Government Initiatives
      • 24.1.6. Investments
      • 24.1.7. Major Companies
    • 24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 24.7. Brazil Anti-Asthmatics And COPD Drugs Market
    • 24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  25. 25. Middle East Anti-Asthmatics And COPD Drugs Market
    • 25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
      • 25.1.1. Region Information
      • 25.1.2. Market Information
      • 25.1.3. Background Information
      • 25.1.4. Government Initiatives
      • 25.1.5. Major Associations
      • 25.1.6. Taxes Levied
      • 25.1.7. Major Companies
    • 25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  26. 26. Africa Anti-Asthmatics And COPD Drugs Market
    • 26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
      • 26.1.1. Region Information
      • 26.1.2. Market Information
      • 26.1.3. Background Information
      • 26.1.4. Government Initiatives
      • 26.1.5. Major Associations
      • 26.1.6. Taxes Levied
      • 26.1.7. Investments
      • 26.1.8. Major Companies
    • 26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  27. 27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape
    • 27.1. Company Profiles
    • 27.2. GlaxoSmithKline plc.
      • 27.2.1. Company Overview
      • 27.2.2. Products And Services
      • 27.2.3. Business Strategy
      • 27.2.4. Financial Overview
    • 27.3. AstraZeneca plc.
      • 27.3.1. Company Overview
      • 27.3.2. Products And Services
      • 27.3.3. Business Strategy
      • 27.3.4. Financial Overview
    • 27.4. Boehringer-Ingelheim GmbH
      • 27.4.1. Company Overview
      • 27.4.2. Products And Services
      • 27.4.3. Business Strategy
      • 27.4.4. Financial Overview
    • 27.5. F. Hoffmann-La Roche Ltd
      • 27.5.1. Company Overview
      • 27.5.2. Products And Services
      • 27.5.3. Business Strategy
      • 27.5.4. Financial Overview
    • 27.6. Novartis AG
      • 27.6.1. Company Overview
      • 27.6.2. Products And Services
      • 27.6.3. Business Strategy
      • 27.6.4. Financial Overview
  28. 28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
    • 28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical
    • 28.2. ResMed Acquired Propeller Health
    • 28.3. Circassia Acquired AstraZeneca’s COPD Treatment Tudorza
    • 28.4. RecipharmAB Acquired Sanofi’s Inhalation Contract Manufacturing Business
    • 28.5. Mast Therapeutics, Inc. Merged With Savara Inc.
    • 28.6. Mylan N.V. Acquired Majority Stake In Meda AB
    • 28.7. Vectura Group Merged With Skyepharma
    • 28.8. Recordati Acquired Italchimici S.p.A.
    • 28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc.
  29. 29. Market Background: Respiratory Diseases Drugs Market
    • 29.1. Respiratory Diseases Drugs Market Characteristics
      • 29.1.1. Market Definition
      • 29.1.2. Segmentation By Type
      • 29.1.3. Anti-Asthmatics And COPD Drugs
      • 29.1.4. Cough And Cold Preparations
    • 29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, Value ($ Billion)
    • 29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
    • 29.4. Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast, By Region
  30. 30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies
    • 30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Countries Offering Most New Opportunities
    • 30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities
    • 30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Growth Strategies
      • 30.3.1. Market Trend Based Strategies
      • 30.3.2. Competitor Strategies
  31. 31. Global Anti-Asthmatics And COPD Drugs Market Recommendations
    • 31.1. Conclusions
    • 31.2. Recommendations
      • 31.2.1. Product
      • 31.2.2. Place
      • 31.2.3. Price
      • 31.2.4. Promotion
  32. 32. Appendix
    • 32.1. Market Data Sources
    • 32.2. Research Methodology
    • 32.3. Currencies
    • 32.4. Research Inquiries
    • 32.5. The Business Research Company
    • 32.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  • Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019
  • Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019
  • Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
  • Table 5: Prevalence Of Asthma, 2014-2017
  • Table 6: Prevalence Of COPD, 2014-2017
  • Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Table 24: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 25:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 26: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 27: Air Pollution And Air Quality Index, Asia-Pacific Countries
  • Table 28: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 29: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 30: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 31: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 35: China Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 36: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 37: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 38: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 39: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 40: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 41: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 43: India Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 44: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 45: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 46: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 47: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 49: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 50:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 51: Japan Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 52: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 53: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 54: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 55: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 56: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 57: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 58: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 59: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 60: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 61: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 62: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 63: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 65: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 66: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 67: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 69: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 70: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 71: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 72: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 73: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 74: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 75: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 77:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 78: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 79: Air Pollution And Air Quality Index in 2018, Western Europe Countries
  • Table 80: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 81: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 82: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 83: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 84: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 85: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 87: UK Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 88: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 89: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 90: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 91: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 92: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 93: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 94: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 95: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 96: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 97: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 98: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 99: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 100: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 101: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 102: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 103: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 104: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 105: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 106:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 107:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 108: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 109: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 110: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 111: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 112: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 113: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 114: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 115: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 116: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 117: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 118: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 119: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 120: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 121:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 122:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 123: North America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 124: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 125: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 126: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 127: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 128: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 129: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 130:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 131: USA Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 132: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 133: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 134: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 135: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 137: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 138:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 139:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 140: South America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 141: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 142: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 143: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 144: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 145: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 146: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 147: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 148: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 149: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 150: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 151: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 152: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 153:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 154:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 155: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 156: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 157: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 158: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 159: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 161: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 162:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 163:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 164: Africa Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 165: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 166: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 167: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 168: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 169: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 170: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 171: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 172: GlaxoSmithKline – Financial Performance, 2015 – 2019, $ Billion
  • Table 173: AstraZeneca plc. –  Financial Performance2015 – 2019, $ Billion
  • Table 174: Boehringer Ingelheim GmbH – Financial Performance, 2015  – 2019, $ Billion
  • Table 175: F. Hoffmann-La Roche Ltd. – Financial Performance, 2015 – 2019, $ Billion
  • Table 176: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 177: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Table 178: Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Table 179: Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 180: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Country
  • Table 181: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, Segmentation By Drug Class
  • Table 182: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Type Of End User
  • Table 183: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Distribution Channel
  • Table 184: Anti-Asthmatics And COPD Drugs Market Data Sources

List Of Figures

    Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
  • Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
  • Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
  • Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
  • Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
  • Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
  • Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
  • Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
  • Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs
  • Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 99: GlaxoSmithKline – Financial Performance, 2015 – 2019, $ Billion
  • Figure 100: AstraZeneca plc. – Financial Performance2015 –  2019, $ Billion
  • Figure 101: Boehringer Ingelheim GmbH – Financial Performance, 2015 – 2019, $ Billion
  • Figure 102: F. Hoffmann-La Roche Ltd – Financial Performance, 2015 – 2019, $ Billion
  • Figure 103: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Figure 105: Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Figure 106: Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cervical Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Central Nervous System Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Checkpoint Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Culture Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell And Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
TNF Alpha Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
HER2 Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Interleukin Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Nucleic Acid Based Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Protein Inhibitors Global Market Report 2021: COVID 19 Growth And Change to 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)